MODULATION OF DOPAMINE D-3 RECEPTOR-BINDING BY N-ETHYLMALEIMIDE AND NEUROTENSIN

被引:23
作者
LIU, Y [1 ]
HILLEFORSBERGLUND, M [1 ]
VONEULER, G [1 ]
机构
[1] KAROLINSKA INST,DEPT NEUROSCI,S-17177 STOCKHOLM,SWEDEN
关键词
DOPAMINE RECEPTOR; 7-[H-3]HYDROXY-N; N-DI-N-PROPYL-2-AMINOTETRALIN; G PROTEIN; RACLOPRIDE; REMOXIPRIDE; N-PROPYLNORAPOMORPHINE; QUINPIROLE; MAGNESIUM;
D O I
10.1016/0006-8993(94)90045-0
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
GTP or G protein inactivation by N-ethylmaleimide reduced the B-max value but not the K-D value of 7-[H-3]hydroxy-N,N-di-n-propyl-2-aminotetralin ([H-3]7-OH-DPAT) binding in the rat subcortical limbic area. Neurotensin (10 nM) increased the K-D and the B-max values of [3H]7-OH-DPAT binding, and these effects persisted also following N-ethylmaleimide pretreatment. N-Propylnorapomorphine, quinpirole, raclopride, and remoxipride inhibited [H-3]7-OH-DPAT binding with K-i values of 0.093, 1.97, 10.6, and 710 nM, respectively. These findings indicate that the D-3 receptor is coupled to G proteins in the brain, and that neurotensin can modulate D-3 agonist binding by a G protein-independent mechanism.
引用
收藏
页码:343 / 348
页数:6
相关论文
共 23 条
[1]   NEUROTENSIN INVITRO MARKEDLY REDUCES THE AFFINITY IN SUBCORTICAL LIMBIC N-PROPYLNORAPOMORPHINE-H-3 BINDING-SITES [J].
AGNATI, LF ;
FUXE, K ;
BENFENATI, F ;
BATTISTINI, N .
ACTA PHYSIOLOGICA SCANDINAVICA, 1983, 119 (04) :459-461
[2]   ISOMERIC SELECTIVITY AT DOPAMINE-D(3) RECEPTORS [J].
BALDESSARINI, RJ ;
KULA, NS ;
MCGRATH, CR ;
BAKTHAVACHALAM, V ;
KEBABIAN, JW ;
NEUMEYER, JL .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 239 (1-3) :269-270
[3]   EFFECT OF TRH AND DOPAMINE ON CYCLIC-AMP LEVELS IN ENRICHED MAMMOTROPH AND THYROTROPH CELLS [J].
BARNES, GD ;
BROWN, BL ;
GARD, TG ;
ATKINSON, D ;
EKINS, RP .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1978, 12 (03) :273-284
[4]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[5]   MODEL SYSTEMS FOR THE STUDY OF 7-TRANSMEMBRANE-SEGMENT RECEPTORS [J].
DOHLMAN, HG ;
THORNER, J ;
CARON, MG ;
LEFKOWITZ, RJ .
ANNUAL REVIEW OF BIOCHEMISTRY, 1991, 60 :653-688
[6]  
ELMESTIKAWY S, 1986, J NEUROCHEM, V46, P12
[7]   A COMPARISON OF THE POTENCIES OF VARIOUS DOPAMINE RECEPTOR AGONISTS IN MODELS FOR PRE-SYNAPTIC AND POSTSYNAPTIC RECEPTOR ACTIVITY [J].
FEENSTRA, MGP ;
SUMNERS, C ;
GOEDEMOED, JH ;
DEVRIES, JB ;
ROLLEMA, H ;
HORN, AS .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1983, 324 (02) :108-115
[8]  
GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151
[9]   COMPARISON OF THE INVITRO RECEPTOR-BINDING PROPERTIES OF N-[H-3]METHYLSPIPERONE AND [H-3] RACLOPRIDE TO RAT AND HUMAN BRAIN MEMBRANES [J].
HALL, H ;
WEDEL, I ;
HALLDIN, C ;
KOPP, J ;
FARDE, L .
JOURNAL OF NEUROCHEMISTRY, 1990, 55 (06) :2048-2057
[10]   MULTIPLE RECEPTORS FOR DOPAMINE [J].
KEBABIAN, JW ;
CALNE, DB .
NATURE, 1979, 277 (5692) :93-96